RNAi相关文章（for free）
Prospects of RNA interference therapy for cancer
S I Pai, Y-Y Lin, B Macaes, A Meneshian, C-F Hung and T-C Wu
Gene Ther 13: 464-477; advance online publication, December 8, 2005; doi:10.1038/sj.gt.3302694
Abstract | Full Text | PDF
RNA interference in embryonic stem cells and the prospects for future therapies
A Heidersbach, A Gaspar-Maia, M T McManus and M Ramalho-Santos
Gene Ther 13: 478-486; advance online publication, February 16, 2006; doi:10.1038/sj.gt.3302723
Abstract | Full Text | PDF
Viral-based modelling and correction of neurodegenerative diseases by RNA interference
C Raoul, S D Barker and P Aebischer
Gene Ther 13: 487-495; advance online publication, December 1, 2005; doi:10.1038/sj.gt.3302690
Abstract | Full Text | PDF
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
J Weiler, J Hunziker and J Hall
Gene Ther 13: 496-502; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302654
Abstract | Full Text | PDF
Induction of stable RNA interference in mammalian cells
Bryan R Cullen
Gene Ther 13: 503-508; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302656
Abstract | Full Text | PDF
Target selectivity in mRNA silencing
N Aronin
Gene Ther 13: 509-516; advance online publication, February 16, 2006; doi:10.1038/sj.gt.3302726
Abstract | Full Text | PDF
RNA knockdown as a potential therapeutic strategy in Parkinson's disease
F P Manfredsson, A S Lewin and R J Mandel
Gene Ther 13: 517-524; advance online publication, November 3, 2005; doi:10.1038/sj.gt.3302669
Abstract | Full Text | PDF
RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases
E M Denovan-Wright and B L Davidson
Gene Ther 13: 525-531; advance online publication, October 20, 2005; doi:10.1038/sj.gt.3302664
Abstract | Full Text | PDF
Antiviral RNAi therapy: emerging approaches for hitting a moving target- FREE
J N Leonard and D V Schaffer
Gene Ther 13: 532-540; advance online publication, September 22, 2005; doi:10.1038/sj.gt.3302645
Abstract | Full Text | PDF
The silent treatment: siRNAs as small molecule drugs FREE
D M Dykxhoorn, D Palliser and J Lieberman
Gene Ther 13: 541-552; advance online publication, January 5, 2006; doi:10.1038/sj.gt.3302703
Abstract | Full Text | PDF
Lentiviral-mediated delivery of siRNAs for antiviral therapy -FREE
K V Morris and J J Rossi
Gene Ther 13: 553-558; advance online publication, January 5, 2006; doi:10.1038/sj.gt.3302688
Abstract | Full Text | PDF
Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders -FREE
P A Campochiaro
Gene Ther 13: 559-562; advance online publication, September 29, 2005; doi:10.1038/sj.gt.3302653
Abstract | Full Text | PDF
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors -FREE
D Grimm and M A Kay
Gene Ther 13: 563-575; advance online publication, February 2, 2006; doi:10.1038/sj.gt.3302727
Abstract | Full Text | PDF
Allele-specific RNA interference for neurological disease -FREE
E Rodriguez-Lebron and H L Paulson
Gene Ther 13: 576-581; advance online publication, December 15, 2005; doi:10.1038/sj.gt.3302702
Abstract | Full Text | PDF
上一篇：RNAi off-target 效应 下一篇：RNAi载体pSIREN-DNR?Vector
